[Form 4] Acacia Research Corporation Insider Trading Activity

Rhea-AI Filing Summary

Zambito Michael SIKORYAK, identified on the filing as the issuer's Chief Financial Officer, reported a purchase of 7,700 shares of Acacia Research Corporation (ACTG) on 08/11/2025. The transaction was coded P for a purchase and was executed at a weighted average price of $3.2658, with the filing noting component trades priced between $3.25 and $3.32. Following the transaction the reporting person beneficially owned 7,700 shares in a direct capacity.

The Form 4 was signed by an attorney-in-fact, Jennifer Graff, on 08/12/2025. No derivative transactions or other securities classes are reported on this filing, and no amendments or additional material items are included.

Positive

• Insider purchase disclosed: CFO acquired 7,700 ACTG shares, demonstrating direct purchase and alignment with the issuer
• Complete disclosure: Filing includes weighted average price $3.2658 and footnote explaining the trade price range $3.25–$3.32

Negative

• None.

Insights

Financial Analyst

TL;DR: CFO purchased 7,700 ACTG shares at a weighted average price of $3.2658; transaction is disclosed via Form 4.

The filing documents a straightforward Section 16 purchase by the reporting officer on 08/11/2025. The disclosed weighted average price and the footnoted execution range ($3.25–$3.32) indicate multiple trades aggregated on a single Form 4. The absolute value of the purchase (~$25k) is small relative to typical market-capitalization thresholds, so the transaction is unlikely to be material to Acacia Research's valuation by itself. The disclosure is timely and complete for the reported non-derivative security.

Corporate Governance Expert

TL;DR: Insider purchase properly reported; signature by attorney-in-fact is included and no conflicts or derivative holdings are disclosed.

The Form 4 shows the officer's direct acquisition of common stock and includes the explanatory footnote about weighted average pricing, satisfying disclosure expectations. The filing is signed by an attorney-in-fact (Jennifer Graff) on 08/12/2025, which is permissible when properly authorized. There are no indirect holdings or plan-based transactions disclosed, and no indications of unusual reporting practices in the submitted content.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zambito Michael SIKORYAK

(Last) (First) (Middle)

767 THIRD AVENUE

6TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ACACIA RESEARCH CORP [ ACTG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
ACTG Common Stock	08/11/2025		P		7,700	A	$3.2658(1)	7,700	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.25 to $3.32, inclusive. The Reporting Person undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form.

Remarks:

	Jennifer Graff, Attorney-in-fact	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Acacia Research (ACTG) disclose on this Form 4?

The Form 4 reports that Zambito Michael SIKORYAK, the issuer's Chief Financial Officer, purchased 7,700 shares on 08/11/2025.

At what price were the ACTG shares purchased in the Form 4 filing?

The shares were reported at a weighted average price of $3.2658, with individual trades in the range $3.25 to $3.32.

How many ACTG shares does the reporting person own after the transaction?

Following the reported purchase the reporting person beneficially owned 7,700 shares, held in a direct capacity.

Was the Form 4 signed and when was it filed?

The Form 4 includes a signature block executed by Jennifer Graff, attorney-in-fact on 08/12/2025 reflecting the reported 08/11/2025 transaction date.

Did the filing report any derivative transactions or plan-based trades for ACTG?

No. Table II (derivative securities) contains no entries and the filing indicates a non-derivative purchase only.